Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation.

Diabetes has been identified as an important risk factor for infection. But relatively little is known about how diabetes alters the inflammatory response to bacteria. The objective of this study was to investigate how diabetes affects host-bacteria interactions by focusing on the inflammatory response in a connective tissue setting. Diabetic (db/db) and control (db/+) mice were inoculated with Porphyromonas gingivalis, a pathogen associated with bite wounds and periodontal disease. The response was measured histologically or by the expression of inflammatory cytokines. By quantitative histologic analysis, there was little difference between the diabetic and control mice on day 1. On day 3, however, the inflammatory infiltrate had subsided in the control group, whereas it had not in the diabetic group (p<0.05). Similar results were noted at the molecular level by the persistent expression of tumor necrosis factor-alpha (TNF-alpha) and the chemokines MCP-1 and MIP-2. The importance of TNF in this process was demonstrated by reversal of the prolonged chemokine expression by specific inhibition of TNF with Enbrel. These results indicate that cytokine dysregulation associated with prolonged TNF expression represents a mechanism through which bacteria may induce a more damaging inflammatory response in diabetic individuals.

[1]  I. Brook.  Microbiology and management of human and animal bite wound infections. , 2003, Primary care.

[2]  R. Cooper,et al.  Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[3]  Tun-Yi Hsu,et al.  Bacteria Induce Osteoclastogenesis via an Osteoblast-Independent Pathway , 2002, Infection and Immunity.

[4]  H. Vlassara,et al.  Diabetes and advanced glycation endproducts , 2002, Journal of internal medicine.

[5]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[6]  D. Graves,et al.  Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection , 2001, Journal of dental research.

[7]  T. Kislinger,et al.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.

[8]  M. Kibata,et al.  Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus , 2001 .

[9]  W. Ricart,et al.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. , 2001, The Journal of clinical endocrinology and metabolism.

[10]  R. Stolk,et al.  Cytokine secretion is impaired in women with diabetes mellitus , 2000, Advances in experimental medicine and biology.

[11]  T. Jenssen,et al.  Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. , 2000, Diabetes.

[12]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[13]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[14]  Y. Hattori,et al.  Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. , 2000, Kidney international.

[15]  U. Boelsterli,et al.  Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes. , 2000, Biochemical pharmacology.

[16]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[17]  A. Karchmer,et al.  Infections in patients with diabetes mellitus. , 1999, The New England journal of medicine.

[18]  S. Tennenberg,et al.  Absence of lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with diabetes. , 1999, Archives of surgery.

[19]  C. Cutler,et al.  Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. , 1999, Journal of periodontology.

[20]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[21]  L. Kesavalu,et al.  Bone Resorption Caused by Three Periodontal Pathogens In Vivo in Mice Is Mediated in Part by Prostaglandin , 1998, Infection and Immunity.

[22]  S. Takashiba,et al.  Periodontal disease as a complication of diabetes mellitus. , 1998, Annals of periodontology.

[23]  S. Edelman,et al.  Importance of glucose control. , 1998, The Medical clinics of North America.

[24]  A. Desfaits,et al.  Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment , 1998, Diabetes Care.

[25]  B. Spiegelman,et al.  Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. , 1997, The Journal of clinical investigation.

[26]  J. Patterson,et al.  Bacterial urinary tract infections in diabetes. , 1997, Infectious disease clinics of North America.

[27]  R. Arnold,et al.  Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. , 1997, Journal of periodontology.

[28]  B. Kulseng,et al.  TNF Production from Peripheral Blood Mononuclear Cells in Diabetic Patients after Stimulation with Alginate and Lipopolysaccharide , 1996, Scandinavian journal of immunology.

[29]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[30]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[31]  H. Löe.  Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.

[32]  E. Goldstein.  Bite wounds and infection. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  S. Yagihashi,et al.  Bacterial Phagocytosis and Intracellular Killing by Alveolar Macrophages in BB Rats , 1988, Diabetes.

[34]  D. Coleman,et al.  Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice. , 1981, Metabolism: clinical and experimental.

[35]  K. Hummel,et al.  Hyperinsulinemia in pre-weaning diabetes (db) mice , 1974, Diabetologia.

[36]  A Mowat,et al.  Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. , 1971, The New England journal of medicine.

[37]  W. Wood,et al.  STUDIES ON THE EFFECT OF EXPERIMENTAL NONKETOTIC DIABETES MELLITUS ON ANTIBACTERIAL DEFENSE , 1966, The Journal of experimental medicine.

[38]  K. Tsuchihashi,et al.  Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.

[39]  R. Strieter,et al.  Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. , 1995, Current eye research.

[40]  T. Deckert,et al.  Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. , 1992, Hormone and metabolic research. Supplement series.